Mr. Greco is an experienced trial lawyer, having tried numerous patent infringement, and commercial cases before judges and juries. His practice has concentrated on patent litigation in the past twenty-five years. He has represented major pharmaceutical, chemical, and biotechnology companies in litigations on patents claiming pharmaceutical compounds, recombinant proteins, pharmaceutical formulations, drug delivery systems, immunoassays and devices, nucleic acid testing, recombinant cell research tools, transgenic animals and processes for producing recombinant products. His work includes several challenges to abbreviated new drug applications on the world’s leading drugs. Outside the life sciences area, he has handled cases concerning catalysts, temperature measurement devices, jet engine fan blades, voice recorders with computer control capabilities and computer displays. Mr. Greco has also consulted on anti-trust matters related to patent activities. He has lectured on patent litigation topics to various professional groups and at in house programs including for Pfizer, Inc., sanofi-aventis, Bristol Myers-Squibb, and Novartis. He has conducted numerous claim construction hearings, including a successful hearing in Chiron Corporation v F Hoffman-LaRoche Ltd concerning the pioneering hepatitis C virus cloning. Prior to joining the Firm, Mr. Greco practiced law at Kaye Scholer LLP for twenty-five years and was a partner for over fifteen years in its patent litigation group. He is a co-author of Pharmaceutical and Biotech Patent Law (PLI 2007). Mr. Greco was named as one of New York Super Lawyers for Intellectual Property in 2007-2010. He practices through Richard G. Greco PC.
